BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31429981)

  • 1. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
    Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
    Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
    Evangelista MT; North JP
    J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merkel cells and sclerosing epithelial neoplasms.
    Abesamis-Cubillan E; El-Shabrawi-Caelen L; LeBoit PE
    Am J Dermatopathol; 2000 Aug; 22(4):311-5. PubMed ID: 10949455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcystic adnexal carcinoma versus desmoplastic trichoepithelioma: a comparative study.
    Tse JY; Nguyen AT; Le LP; Hoang MP
    Am J Dermatopathol; 2013 Feb; 35(1):50-5. PubMed ID: 22722464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
    Merritt BG; Snow SN; Longley BJ
    Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J; McNiff JM
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
    Mitcov M; Scrivener Y; Cribier B
    Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque-type syringoma: two cases misdiagnosed as microcystic adnexal carcinoma.
    Suwattee P; McClelland MC; Huiras EE; Warshaw EM; Lee PK; Kaye VN; McCalmont TH; Niehans GA
    J Cutan Pathol; 2008 Jun; 35(6):570-4. PubMed ID: 18005172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K; Krahl D
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
    Krahl D; Sellheyer K
    Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
    Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystic adnexal carcinoma associated with multiple benign syringomatous proliferations: a report of two cases.
    Liang CA; Busam KJ; Nehal KS
    Dermatol Surg; 2011 Oct; 37(10):1515-8. PubMed ID: 21649791
    [No Abstract]   [Full Text] [Related]  

  • 14. Syringocystadenoma papilliferum: Unusual location.
    Elfatoiki F; Khadir K; Ouakadi A; Azzouzi S; Bahechar N; Benchikhi H
    Dermatol Online J; 2011 Jun; 17(6):7. PubMed ID: 21696687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors.
    Vidal CI; Goldberg M; Burstein DE; Emanuel HJ; Emanuel PO
    Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringomatous carcinoma: case report of a rare tumor entity.
    El khannoussi B; Hechlaf H; Lalya I; Oukabli M; Al Bouzidi A; Ortonne N
    Pan Afr Med J; 2012; 12():76. PubMed ID: 23077697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell carcinoma with thickened basement membrane: a variant that resembles some benign adnexal neoplasms.
    El-Shabrawi L; LeBoit PE
    Am J Dermatopathol; 1997 Dec; 19(6):568-74. PubMed ID: 9415612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic trichoepitheliomas with perineural involvement.
    Harvey NT; Leecy T; Beer TW; Wood BA
    Pathology; 2013 Feb; 45(2):196-8. PubMed ID: 23250043
    [No Abstract]   [Full Text] [Related]  

  • 19. Desmoplastic trichoepithelioma: report of a unique periocular case.
    Kirzhner M; Jakobiec FA; Borodic G
    Ophthalmic Plast Reconstr Surg; 2012; 28(5):e121-3. PubMed ID: 22366669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.
    Obaidat NA; Alsaad KO; Ghazarian D
    J Clin Pathol; 2007 Feb; 60(2):145-59. PubMed ID: 16882695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.